Latest filings (excl ownership)
15-12G
Securities registration termination
21 Mar 24
EFFECT
Notice of effectiveness
12 Mar 24
EFFECT
Notice of effectiveness
12 Mar 24
EFFECT
Notice of effectiveness
12 Mar 24
25-NSE
Exchange delisting
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
POS AM
Prospectus update (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
11 Mar 24
8-K
Termination of a Material Definitive Agreement
11 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
8 Mar 24
DEFA14A
Additional proxy soliciting materials
28 Feb 24
8-K
Other Events
28 Feb 24
DEFA14A
Additional proxy soliciting materials
22 Feb 24
8-K
Other Events
22 Feb 24
DEFM14A
Proxy related to merger
8 Feb 24
PREM14A
Preliminary proxy related to merger
29 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
29 Jan 24
8-K
Other Events
26 Jan 24
DFAN14A
Additional proxy materials by non-management
10 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
DFAN14A
Additional proxy materials by non-management
8 Jan 24
DEFA14A
Additional proxy soliciting materials
8 Jan 24
8-K
Entry into a Material Definitive Agreement
8 Jan 24
S-8
Registration of securities for employees
5 Jan 24
424B3
Prospectus supplement
22 Dec 23
EFFECT
Notice of effectiveness
20 Dec 23
S-3
Shelf registration
8 Dec 23
8-K
Departure of Directors or Certain Officers
28 Nov 23
8-K
Other Events
24 Nov 23
424B5
Prospectus supplement for primary offering
24 Nov 23
10-Q
2023 Q3
Quarterly report
9 Nov 23
8-K
Harpoon Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
Latest ownership filings
SC 13G
GLAZER CAPITAL, LLC
18 Mar 24
SC 13D/A
GAMCO INVESTORS, INC. ET AL
13 Mar 24
4
Vijay K Lathi
11 Mar 24
4
LAUREN P SILVERNAIL
11 Mar 24
4
RONALD HUNT
11 Mar 24
4
Luke Nathaniel Walker
11 Mar 24
4
Scott Dunseth Myers
11 Mar 24
4
Mark Chin
11 Mar 24
4
JONATHAN G DRACHMAN
11 Mar 24
4
Andrew R Robbins
11 Mar 24
4
Frank J Lanza
11 Mar 24
4
JULIA MARIE EASTLAND
11 Mar 24
4
JOSEPH S BAILES
11 Mar 24
4
James B Bucher
11 Mar 24
4
Change in insider ownership
11 Mar 24
SC 13D/A
MERCK SHARP & DOHME LLC
11 Mar 24
SC 13D
GAMCO INVESTORS, INC. ET AL
27 Feb 24
SC 13D/A
Arix Bioscience plc
21 Feb 24
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
New Leaf Ventures III, L.P.
13 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13D/A
MPM BioVentures 2014, L.P.
12 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G/A
Soleus Private Equity Fund III, L.P.
6 Feb 24
SC 13G/A
INTEGRATED CORE STRATEGIES (US) LLC
19 Jan 24
SC 13D
MERCK SHARP & DOHME LLC
18 Jan 24
3
Initial statement of insider ownership
17 Jan 24
4
Luke Nathaniel Walker
9 Jan 24
4
Frank J Lanza
9 Jan 24
4
JULIA MARIE EASTLAND
9 Jan 24
4
Scott Dunseth Myers
3 Jan 24
4
RONALD HUNT
3 Jan 24
4
Mark Chin
3 Jan 24
4
James B Bucher
26 Dec 23
3
James B Bucher
26 Dec 23
4
Luke Nathaniel Walker
28 Nov 23
4
Frank J Lanza
28 Nov 23
4
JULIA MARIE EASTLAND
28 Nov 23
4
LAUREN P SILVERNAIL
28 Nov 23